AlphAIAlphAI — Financial news for AI agents
simplywall.stSEP 42 min read

CEO & Chairman of Amrize Jan Jenisch Buys 1.3% More Shares

Amrize AG CEO Jan Jenisch bought 1.3% more shares, spending CHF1.0m at CHF34.51 per share. This follows an earlier purchase at a higher price, suggesting confidence in the company. Insiders own 7.3% of Amrize, worth CHF1.4b. No insider sales were reported in the last year.

Original reporting
simplywall.st
Published Sep 4, 2026, 4:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 5, 2026, 12:11 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
CEO & Chairman of Amrize Jan Jenisch Buys 1.3% More Shares — source image
Source · simplywall.st
Decision brief

The 30-second read

Low
01

Why it matters

The disclosed insider buying could be viewed as a modest bullish signal but the scale is limited.

02

Market read

Insider purchase news may affect short-term sentiment for Amrize AG but limited broader market impact.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 4/10Novelty 4/10Timing: today

Background

Amrize AG is a Swiss listed company; the article reports recent insider purchases by CEO Jan Jenisch.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

Insider buying may not signal long-term upside if the purchase is small relative to float.

Key entities

  • Person
    Jan Jenisch

    CEO & Chairman of Amrize AG

  • Company
    Amrize AG

    Swiss company referenced in the insider transaction report

Read at source← All news

Related articles

SEP 16
Low

Amrize (SWX:AMRZ) Reshuffles Building Envelope Leadership As Fair Value Stays In Focus

Amrize (SWX:AMRZ) appointed Mario Gross as President of its Building Envelope division following Jake Gosa's resignation. The company's shares trade at CHF32.07, down 15.3% over the past month and 28.5% over the last quarter. Analysts suggest a fair value of CHF46.66, citing potential earnings power and margin expansion from the ASPIRE synergy program. The P/E ratio is 17.3x, compared to an estimated fair ratio of 30.5x and a peer average of 48.6x.

simplywall.st2 min
SEP 2
High

BofA downgrades Amrize to underperform, cuts price target on slower growth outlook

Bank of America downgraded Amrize to Underperform, cutting its price target to $40 from $50 due to slower earnings growth, market risks, and valuation concerns. The brokerage lowered its 2027-28 adjusted EBITDA and EPS estimates, citing stable U.S. cement prices, Canadian demand pressure from U.S. tariffs, and vulnerable roofing margins. BofA forecasts adjusted EBITDA growth of 3% and adjusted EPS growth of 6% annually over 2026-28, excluding large acquisitions. The bank also trimmed its buildin

investing.com2 min
SEP 2
$AMRZMed

BofA downgrades Amrize stock on growth concerns, cuts price target to $40

BofA Securities downgraded Amrize Ltd (NYSE:AMRZ) to Underperform, cutting its price target to $40 from $50. The stock is near its 52-week low, down 20% YTD. BofA reduced 2027-28 EBITDA estimates by 3%, citing growth concerns, U.S. cement price stability, and Canada macro risks. Amrize's Q2 earnings missed estimates, though revenue beat forecasts. Other analysts also downgraded the stock due to earnings misses and management changes.

investing.com2 min
SEP 2
High

Why is Amrize stock sliding today?

Amrize AG (AMRZ) fell 2.9% to CHF 34.13 after JPMorgan downgraded it to Neutral, citing executive departures and missed earnings. The stock hit a 52-week low of CHF 33.64, with JPMorgan lowering its price target to $52 from $57. The broader market showed no significant movement, indicating the decline is company-specific.

investing.com2 min